Study: Following CDC Guidelines Reduces Blood Infections from Dialysis Compliance with the recommendations developed by the United States Centers for Disease Control and Prevention (CDC) may lead to a reduction in the rates of bloodstream infections by up to one-half among patients in dialysis facilities, a current study reveals.
In the analysis, which was published online in the American Journal of Kidney Diseases, a group of experts led by head of CDC's dialysis safety efforts Dr. Priti Patel, reportedly analyzed data reported by 17 outpatient dialysis facilities to the National Healthcare Safety Network. After comparing infection rates before and after CDC interventions have been introduced, the research team reportedly found a 32 percent decrease in overall bloodstream infections and a 54 percent decrease in vascular access-related bloodstream infections. CDC interventions consistently used by these dialysis facilities included the use of alcohol-based chlorhexidine for
catheter exit-site care, staff training, and competency assessments focused on catheter care, vascular access care audits, and adherence to aseptic technique and hand hygiene, according to an announcement by the CDC.
“Dialysis patients are particularly vulnerable to infections,” states Dr. Patel in a press release. “We now know that it is possible to significantly reduce the infections among dialysis patients by following CDC's checklist and tools. If all dialysis facilities nationwide were using the CDC interventions, we could see dramatic reductions in infections and adverse outcomes in this population.”
Bloodstream infections are one of the common complications that may occur in kidney failure patients on dialysis, medical experts say. Health problems, such as anemia, sleep problems, muscle cramps, itching, and hypotension (low blood pressure), may also arise from dialysis or the underlying kidney problem.
Moreover, some dialysis drug solutions, including GranuFlo, have also been associated with a string of potentially irreversible adverse effects, harboring a series of GranuFlo lawsuits from some patients. See Dialysisinjuryhelpline.com for extensive information concerning the serious health consequences tied to GranuFlo, as well as NaturaLyte.
Sources: *cdc.gov/media/releases/2013/p0513-dialysisinfections.html *renalandurologynews.com/cdc-protocols-preventdialysis-bloodstream-infections/article/293601/ *mayoclinic.com/health/hemodialysis/MY00281/DSECTI ON=risks *fda.gov/medicaldevices/safety/listofrecalls/ucm309990. htm
Compliance with the recommendations developed by the United States Centers for Disease Control and Prevention (CDC) may lead to a reduction...